{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T19:54:09Z","timestamp":1789674849037,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"31","license":[{"start":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T00:00:00Z","timestamp":1214870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,7]]},"DOI":"10.1016\/j.vaccine.2008.04.089","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T11:45:33Z","timestamp":1212493533000},"page":"3903-3908","source":"Crossref","is-referenced-by-count":41,"title":["Predicted long-term persistence of pertussis antibodies in adolescents after an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine, based on mathematical modeling and 5-year observed data"],"prefix":"10.1016","volume":"26","author":[{"given":"F.","family":"Bailleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Coudeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Kolenc-Saban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Bevilacqua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Barreto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Andr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 6","key":"10.1016\/j.vaccine.2008.04.089_bib1","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1097\/01.inf.0000166154.47013.47","article-title":"Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination","volume":"24","author":"Edwards","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.04.089_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","article-title":"Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies","volume":"18","author":"Mattoo","year":"2005","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.vaccine.2008.04.089_bib3","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1097\/01.inf.0000160708.43944.99","article-title":"Epidemiology of pertussis","volume":"24","author":"Tan","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.04.089_bib4","first-page":"1","article-title":"Summary of notifiable diseases, United States, 2003","volume":"52","author":"Centers for Disease Control and Prevention","year":"2003","journal-title":"Morb Mortal Wkly Rep"},{"issue":"52","key":"10.1016\/j.vaccine.2008.04.089_bib5","first-page":"1213","article-title":"Notifiable diseases\/deaths in selected cities, weekly information","volume":"53","author":"Centers for Disease Control and Prevention","year":"2005","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2008.04.089_bib6","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/01.inf.0000145263.37198.2b","article-title":"Infant pertussis: who was the source?","volume":"23","author":"Bisgard","year":"2004","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2008.04.089_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/10647440500068289","article-title":"Seroprevalence of Bordetella pertussis antibodies in mothers and their newborn infants","volume":"13","author":"Gonik","year":"2005","journal-title":"Infect Dis Obstet Gynecol"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2008.04.089_bib8","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1097\/01.inf.0000160909.24879.e6","article-title":"Pertussis sources of infection and routes of transmission in the vaccination era","volume":"24","author":"Schellekens","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"10.1016\/j.vaccine.2008.04.089_bib9","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1542\/peds.2004-2648","article-title":"The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection","volume":"115","author":"Cherry","year":"2005","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.04.089_bib10","first-page":"Q1","article-title":"Recommended childhood and adolescent immunization schedule\u2014United State, January\u2013June 2004","volume":"53","author":"Centers for Disease Control and Prevention (CDC)","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2008.04.089_bib11","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.vaccine.2004.05.030","article-title":"High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria\u2013tetanus-acellular pertussis vaccine","volume":"23","author":"McIntyre","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.089_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1086\/421943","article-title":"Pertussis-specific cell-mediated and humoral immunity in adolescents 3 years after booster immunization with acellular pertussis vaccine","volume":"39","author":"Edelman","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib13","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1086\/422035","article-title":"APERT Study. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study","volume":"190","author":"Le","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1086\/514338","article-title":"Immunity to pertussis 5 years after booster immunization during adolescence","volume":"44","author":"Edelman","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib15","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Level of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis","volume":"16","author":"Storaeter","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.089_bib16","first-page":"275","article-title":"Antibody kinetics and long term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines","volume":"89","author":"Giuliano","year":"1997","journal-title":"Dev Biol Stand"},{"key":"10.1016\/j.vaccine.2008.04.089_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/adc.75.4.298","article-title":"Combined diphtheria, tetanus, pertussis, and Haemophilus influenzae type b vaccines for primary immunisation","volume":"75","author":"Bell","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.vaccine.2008.04.089_bib18","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/infdis\/163.3.559","article-title":"Immune responses to Bordetella pertussis infection and vaccination","volume":"163","author":"Tomoda","year":"1991","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3109\/00365549509019021","article-title":"Response and decline of serum IgG antibodies to pertussis toxin, filamentous hemagglutinin and pertactin in children with pertussis","volume":"27","author":"Isacson","year":"1995","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib20","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1128\/JCM.38.2.800-806.2000","article-title":"Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis","volume":"38","author":"de Melker","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2008.04.089_bib21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1086\/381439","article-title":"Serologic response and antibody-titer decay in adults with pertussis","volume":"38","author":"Heininger","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1001\/jama.269.1.53","article-title":"Adult immunization with acellular pertussis vaccine","volume":"269","author":"Edwards","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2008.04.089_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1086\/314869","article-title":"A randomized clinical trial of acellular pertussis vaccines in healthy adults: dose-response comparisons of 5 vaccines and implications for booster immunization","volume":"180","author":"Keitel","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2008.04.089_bib24","doi-asserted-by":"crossref","first-page":"8172","DOI":"10.1016\/j.vaccine.2007.09.031","article-title":"Humoral immunity 5 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine","volume":"25","author":"Barreto","year":"2007","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.04.089_bib25","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/00006454-200004000-00003","article-title":"Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults","volume":"19","author":"Halperin","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2008.04.089_bib26","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.04.089_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1017\/S0950268802007896","article-title":"Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis","volume":"129","author":"Teunis","year":"2002","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2008.04.089_bib28","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/S0264-410X(99)00539-3","article-title":"Diphtheria antitoxin response to DTP vaccines used in Swedish pertussis vaccine trials, persistence and projection for timing of booster","volume":"18","author":"Tiru","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.089_bib29","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1056\/NEJMoa066092","article-title":"Duration of humoral immunity to common viral and vaccine antigens","volume":"357","author":"Amanna","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.04.089_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.vaccine.2004.06.012","article-title":"Anti-diphtheria antibody seroprotection rates are similar 10 years after vaccination with dTpa or DTPa using a mathematical model","volume":"23","author":"Cheuvart","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.04.089_bib31","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1177\/009286159903300322","article-title":"Statistical models for predicting the duration of vaccine-induced protection","volume":"33","author":"Pigeon","year":"1999","journal-title":"Drug Inform J"},{"key":"10.1016\/j.vaccine.2008.04.089_bib32","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/sim.699","article-title":"Repeated-measures models to evaluate a hepatitis B vaccination programme","volume":"20","author":"Renard","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.vaccine.2008.04.089_bib33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0264-410X(96)00138-7","article-title":"Persistence of antibodies to meningococcal IgA1 protease versus decay of antibodies to group A polysaccharide and Opc protein","volume":"15","author":"Thiesen","year":"1997","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08005380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T23:37:00Z","timestamp":1588721820000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08005380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,7]]},"references-count":33,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2008,7]]}},"alternative-id":["S0264410X08005380"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.04.089","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,7]]}}}